-
Please visit our renewed hhc page featuring Eisai's thoughts
-
-
August 12, 2022
-
August 9, 2022
-
August 4, 2022
-
August 3, 2022
-
July 26, 2022
-
August 8, 2022
-
August 5, 2022
IR “First Quarter Financial Report for the Fiscal Year Ending March 31, 2023”
-
June 17, 2022
IR "Notice of Resolution of the 110th Ordinary General Meeting of Shareholders"
-
May 24, 2022
IR “Notice of Convocation of the 110th Ordinary General Meeting of Shareholders”
-
July 15, 2022
Notification Regarding U.S. Research and Development Subsidiary
-
April 1, 2022
-
November 24, 2021
-
September 22, 2021
EISAI ITALY AWARDED HIGHEST CLASSIFICATION AT SIXTH ANNUAL WELFARE INDEX PMI* IN ITALY
-
April 19, 2021
Eisai formulates the action plan “Diversity & Inclusion 2021”
Sustainability
29 countries 2.05 billion tablets
Number of countries supplied with lymphatic filariasis treatment
and volume supplied (as of July 2022)
Eisai is promoting initiatives for improving access to medicines to contribute to people in developing and emerging countries
